| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Negative Networking and Bridge Burning |
|
Subjects - Negative Networking and Bridge Burning
After years of networking with individuals I began to noti According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ce something rather interesting and I just thought it was ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in bout time I share this with you all. I believe there is so lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ething called; Negative Networking and is more akin to Bri here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ge Burning. It comes from several unfortunate scenarios du d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ing business networking events. One of the most interesti ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc g things I have seen over the years was people who get int easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi o clashes over politics at networking events. Generally mo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t business people will be fairly pro-business and often pu and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s them into a more Libertarian or Republic Perspective or ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t least that is the way it use to be, now you just never k ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ow. I have watched people burn bridges and end up doing ne dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ative networking. Occasionally, I would watch a competito cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin at a networking event get into a clash and not more than tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ten minutes later the person they were talking to was all t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ver me trying to become close friends. Interestingly, enou ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust h my competitor and I would normally be on the same page w y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products en it came to politics. Nevertheless, I would not start in . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de on the politics issue, yet welcomed the new networking par elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ner that my competitor upset, so consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Six Sigma Tools for Process Control How To Find Quick, Free, Job Search Resurces
|